“Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.”, Science, vol. 373, no. 6561, pp. 1372-1377, 2021.
, “Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.”, Science, vol. 373, no. 6561, pp. 1372-1377, 2021.
, “Endpoints for randomized controlled clinical trials for COVID-19 treatments.”, Clin Trials, vol. 17, no. 5, pp. 472-482, 2020.
, “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.”, N Engl J Med, 2020.
, “Remdesivir for the Treatment of Covid-19 - Preliminary Report.”, N Engl J Med, 2020.
, “Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.”, Hum Vaccin Immunother, vol. 17, no. 2, pp. 554-559, 2021.
, “Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.”, N Engl J Med, 2020.
,